132 related articles for article (PubMed ID: 24794251)
1. Infiltration of CD3⁺ and CD68⁺ cells in bladder cancer is subtype specific and affects the outcome of patients with muscle-invasive tumors.
Sjödahl G; Lövgren K; Lauss M; Chebil G; Patschan O; Gudjonsson S; Månsson W; Fernö M; Leandersson K; Lindgren D; Liedberg F; Höglund M
Urol Oncol; 2014 Aug; 32(6):791-7. PubMed ID: 24794251
[TBL] [Abstract][Full Text] [Related]
2. Immunoscore encompassing CD3+ and CD8+ T cell densities in distant metastasis is a robust prognostic marker for advanced colorectal cancer.
Kwak Y; Koh J; Kim DW; Kang SB; Kim WH; Lee HS
Oncotarget; 2016 Dec; 7(49):81778-81790. PubMed ID: 27835889
[TBL] [Abstract][Full Text] [Related]
3. Elevated CD163
Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
[No Abstract] [Full Text] [Related]
4. Age and sex have no impact on expression levels of markers of immune cell infiltration and immune checkpoint pathways in patients with muscle-invasive urothelial carcinoma of the bladder treated with radical cystectomy.
Holland BC; Sood A; Delfino K; Dynda DI; Ran S; Freed N; Alanee S
Cancer Immunol Immunother; 2019 Jun; 68(6):991-997. PubMed ID: 30997535
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of the infiltration of CD163
Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
[TBL] [Abstract][Full Text] [Related]
6. Immunochemistry-based quantification of tumor-infiltrating lymphocytes and immunoscore as prognostic biomarkers in bladder cancer.
Rejeb SB; Elfekih S; Kouki N; Boulma R; Khouni H
J Egypt Natl Canc Inst; 2024 Mar; 36(1):9. PubMed ID: 38523233
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of the lymphocyte-to-monocyte ratio and the tumor-infiltrating lymphocyte to tumor-associated macrophage ratio in patients with stage T3N0M0 esophageal squamous cell carcinoma.
Zhu Y; Li M; Bo C; Liu X; Zhang J; Li Z; Zhao F; Kong L; Yu J
Cancer Immunol Immunother; 2017 Mar; 66(3):343-354. PubMed ID: 27915370
[TBL] [Abstract][Full Text] [Related]
8. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response.
Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W
Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813
[TBL] [Abstract][Full Text] [Related]
9. Relationships between tumor microenvironment and clinicopathological parameters in meningioma.
Ding Y; Qiu L; Xu Q; Song L; Yang S; Yang T
Int J Clin Exp Pathol; 2014; 7(10):6973-9. PubMed ID: 25400783
[TBL] [Abstract][Full Text] [Related]
10. Profiling of Tumour-Infiltrating Lymphocytes and Tumour-Associated Macrophages in Ovarian Epithelial Cancer-Relation to Tumour Characteristics and Impact on Prognosis.
Stout A; Facey N; Bhatnagar A; Rice K; Berditchevski F; Kearns D; Metcalf A; Elghobashy A; Shaaban AM
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38674108
[TBL] [Abstract][Full Text] [Related]
11. Histopathological analysis of tumor microenvironment in adrenocortical carcinoma: Possible effects of in situ disorganized glucocorticoid production on tumor immunity.
Ishikawa Y; Yamazaki Y; Tezuka Y; Omata K; Ono Y; Tokodai K; Fujishima F; Kawanabe S; Katabami T; Ikeya A; Yamashita M; Oki Y; Nanjo H; Satoh F; Ito A; Unno M; Kamei T; Sasano H; Suzuki T
J Steroid Biochem Mol Biol; 2024 Apr; 238():106462. PubMed ID: 38232786
[TBL] [Abstract][Full Text] [Related]
12. Lower cyclooxygenase-2 expression is associated with recurrence of solitary non-muscle invasive bladder carcinoma.
Tadin T; Krpina K; Stifter S; Babarović E; Fučkar Z; Jonjić N
Diagn Pathol; 2012 Nov; 7():152. PubMed ID: 23126361
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Heterogeneity of Molecular Subtypes in Muscle-invasive Bladder Cancer-An Extensive Multiregional Immunohistochemical Analysis.
Schallenberg S; Dragomir MP; Anders P; Ebner B; Volz Y; Eismann L; Rodler S; Casuscelli J; Buchner A; Klauschen F; Stief C; Horst D; Schulz GB
Eur Urol Focus; 2023 Sep; 9(5):788-798. PubMed ID: 37076398
[TBL] [Abstract][Full Text] [Related]
14. Presence, Subtypes, and Prognostic Significance of Tertiary Lymphoid Structures in Urothelial Carcinoma of the Bladder.
Ma G; Jia H; Zhang G; Liang Y; Dong X; Fu G; Wang X; Niu H
Oncologist; 2024 Feb; 29(2):e248-e258. PubMed ID: 37874923
[TBL] [Abstract][Full Text] [Related]
15. Specific subsets of urothelial bladder carcinoma infiltrating T cells associated with poor prognosis.
Guo R; Wang L; Bai S; Kang D; Zhang W; Ding Z; Xing T; Hao M; Liang Y; Jiao B; Zhang G; Ying L; Chen R; Chen X; Zhang W; Wang J; Wan C; Yu C; Wang H; Yang Z
Sci Rep; 2023 Aug; 13(1):12801. PubMed ID: 37550396
[TBL] [Abstract][Full Text] [Related]
16. Metastasis and recurrence patterns in the molecular subtypes of urothelial bladder cancer.
Sjödahl G; Eriksson P; Holmsten K; Abrahamsson J; Höglund M; Bernardo C; Ullén A; Liedberg F
Int J Cancer; 2024 Jan; 154(1):180-190. PubMed ID: 37671617
[TBL] [Abstract][Full Text] [Related]
17. Molecular Urothelial Tumor Cell Subtypes Remain Stable During Metastatic Evolution.
Cox A; Klümper N; Stein J; Sikic D; Breyer J; Bolenz C; Roghmann F; Erben P; Wirtz RM; Wullich B; Ritter M; Hölzel M; Schwamborn K; Horn T; Gschwend J; Hartmann A; Weichert W; Erlmeier F; Eckstein M
Eur Urol; 2024 Apr; 85(4):328-332. PubMed ID: 37031005
[TBL] [Abstract][Full Text] [Related]
18. Deficiency in infiltration of CD8/CD3 positive lymphocytes and macrophages plays a role in lip carcinogenesis: an immunohistochemical study.
Magalhães IA; Costa GAJ; Borges MMF; Carlos ACAM; Mesquita KC; Arruda LMA; Cunha MDPSS; Sousa FB; Silva PGB
Braz J Otorhinolaryngol; 2024; 90(2):101379. PubMed ID: 38219446
[TBL] [Abstract][Full Text] [Related]
19. CD47 expression and tumor-associated immune cells in breast cancer and their correlation with molecular subtypes and prognostic factors.
Celepli P; Karabulut S; Bigat İ; Celepli S; Hücümenoğlu S
Pathol Res Pract; 2022 Oct; 238():154107. PubMed ID: 36088827
[TBL] [Abstract][Full Text] [Related]
20. Circulating extracellular vesicles carrying Firmicutes reflective of the local immune status may predict clinical response to pembrolizumab in urothelial carcinoma patients.
Jingushi K; Kawashima A; Saito T; Kanazawa T; Motooka D; Kimura T; Mita M; Yamamoto A; Uemura T; Yamamichi G; Okada K; Tomiyama E; Koh Y; Matsushita M; Kato T; Hatano K; Uemura M; Tsujikawa K; Wada H; Nonomura N
Cancer Immunol Immunother; 2022 Dec; 71(12):2999-3011. PubMed ID: 35598195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]